Accession Number: | 0001354488-15-005343 |
Date: | 2015-11-16 |
Issuer: | CELLULAR BIOMEDICINE GROUP, INC. (CBMG) |
Original Submission Date: |
CAO WEI (WILLIAM)
19925 STEVENS CREEK BLVD., SUITE 100
CUPERTINO, CA 95014
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2015-11-16 | S | 12,066 | d | $23.55 | 210,452 | direct | ||
COMMON STOCK | 2015-11-17 | S | 14,749 | d | $25.53 | 195,703 | direct | ||
COMMON STOCK | 2015-11-18 | S | 11,231 | d | $22.83 | 184,472 | direct | ||
COMMON STOCK | 2015-11-19 | S | 10,000 | d | $21.15 | 174,472 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the transaction reported was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on june 30, 2015. accordingly, the reporting person had no discretion with regard to the timing of the transaction. |